| Bioactivity | CB07-Exatecan is an ADC drug-Linker conjugate that can be used for the synthesis of ADCs. ADC conjugated with CB07-Exatecan and trastuzumab inhibits the growth of HER2-positive cancer cells. CB07-Exatecan can be used in cancer research[1]. |
| Name | CB07-Exatecan |
| CAS | 2879247-31-9 |
| Formula | C71H94FN11O22 |
| Molar Mass | 1472.56 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Weijia Tang, et al. Method for treating her2-positive solid tumor. Patent WO2023198079A1. |
CB07-Exatecan
CAS: 2879247-31-9 F: C71H94FN11O22 W: 1472.56
CB07-Exatecan is an ADC drug-Linker conjugate that can be used for the synthesis of ADCs. ADC conjugated with CB07-Exate
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.